These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7598142)

  • 1. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people.
    Kalish SC; Bohn RL; Mogun H; Glynn RJ; Gurwitz JH; Avorn J
    J Am Geriatr Soc; 1995 Sep; 43(9):967-73. PubMed ID: 7657936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME; Guthrie SK
    Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing antipsychotic-induced parkinsonism.
    Mamo DC; Sweet RA; Keshavan MS
    Drug Saf; 1999 Mar; 20(3):269-75. PubMed ID: 10221855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
    Ganzini L; Heintz R; Hoffman WF; Keepers GA; Casey DE
    J Geriatr Psychiatry Neurol; 1991; 4(4):222-5. PubMed ID: 1686396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment of extrapyramidal signs in nursing home patients given antipsychotic medication.
    Avorn J; Monane M; Everitt DE; Beers MH; Fields D
    Arch Intern Med; 1994 May; 154(10):1113-7. PubMed ID: 7910451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of levodopa therapy following metoclopramide use.
    Avorn J; Gurwitz JH; Bohn RL; Mogun H; Monane M; Walker A
    JAMA; 1995 Dec; 274(22):1780-2. PubMed ID: 7500509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes.
    Decina P; Mukherjee S; Caracci G; Harrison K
    Am J Psychiatry; 1992 Aug; 149(8):1075-80. PubMed ID: 1353315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
    Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
    Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects.
    Keepers GA; Casey DE
    Am J Psychiatry; 1991 Jan; 148(1):85-9. PubMed ID: 1670616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis and treatment of neuroleptic-induced Parkinsonism.
    Hoffman BF
    Hosp Community Psychiatry; 1981 Feb; 32(2):110-4. PubMed ID: 6115811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic antiparkinsonian therapy in outpatients treated with neuroleptic drugs: a prescription survey.
    Spila-Alegiani S; Diana G; Menniti-Ippolito F; Raschetti R
    Eur J Clin Pharmacol; 1995; 48(6):513-7. PubMed ID: 8582472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of antipsychotic drugs.
    Malhotra AK; Litman RE; Pickar D
    Drug Saf; 1993 Dec; 9(6):429-36. PubMed ID: 7907481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT; Stenson RL
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mianserin in neuroleptic-induced parkinsonism.
    Korsgaard S; Friis T
    Psychopharmacology (Berl); 1986; 88(1):109-11. PubMed ID: 2868480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.